5-Dose Drug for Coronavirus Would Cost $3,120

Gilead Sciences, makers of remdesivir, a drug that has showed promise in treating coronavirus infections, announced it will charge U.S. hospitals $520 a vial, for a total of $3,120, for a patient with private insurance, with most patients needing six vials of the drug over five days. A lower price of $390 per vial will be offered to other governments in developed countries around the world, due to agreements made between Gilead and generic manufacturers to produce remdesivir at a...

Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports